Journal
DEVELOPMENTAL CELL
Volume 30, Issue 3, Pages 295-308Publisher
CELL PRESS
DOI: 10.1016/j.devcel.2014.06.005
Keywords
-
Categories
Funding
- US NIH grants [CA168692, HL57900, R3750286]
- California Breast Cancer Research Program grant [18IB-0020]
- National Cancer Institute of the NIH award [T32CA121938]
Ask authors/readers for more resources
Although integrin alpha v beta 3 is linked to cancer progression, its role in epithelial development is unclear. Here, we show that alpha v beta 3 plays a critical role in adult mammary stem cells (MaSCs) during pregnancy. Whereas alpha v beta 3 is a luminal progenitor marker in the virgin gland, we noted increased alpha v beta 3 expression in MaSCs at midpregnancy. Accordingly, mice lacking alpha v beta 3 or expressing a signaling-deficient receptor showed defective mammary gland morphogenesis during pregnancy. This was associated with decreased MaSC expansion, clonogenicity, and expression of Slug, a master regulator of MaSCs. Surprisingly, alpha v beta 3-deficient mice displayed normal development of the virgin gland with no effect on luminal progenitors. Transforming growth factor beta 2 (TGF-beta 2) induced alpha v beta 3 expression, enhancing Slug nuclear accumulation and MaSC clonogenicity. In human breast cancer cells, alpha v beta 3 was necessary and sufficient for Slug activation, tumorsphere formation, and tumor initiation. Thus, pregnancy-associated MaSCs require a TGF-beta 2/alpha v beta 3/Slug pathway, which may contribute to breast cancer progression and sternness.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available